These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9510164)
1. A role for perforin in activation-induced cell death. Spaner D; Raju K; Radvanyi L; Lin Y; Miller RG J Immunol; 1998 Mar; 160(6):2655-64. PubMed ID: 9510164 [TBL] [Abstract][Full Text] [Related]
2. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Sobek V; Balkow S; Körner H; Simon MM Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333 [TBL] [Abstract][Full Text] [Related]
3. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. Spaner D; Raju K; Rabinovich B; Miller RG J Immunol; 1999 Jan; 162(2):1192-9. PubMed ID: 9916752 [TBL] [Abstract][Full Text] [Related]
4. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164 [TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. Rafi AQ; Zeytun A; Bradley MJ; Sponenberg DP; Grayson RL; Nagarkatti M; Nagarkatti PS J Immunol; 1998 Sep; 161(6):3077-86. PubMed ID: 9743374 [TBL] [Abstract][Full Text] [Related]
7. Perforin-dependent activation-induced cell death acts through caspase 3 but not through caspases 8 or 9. Chen L; Woo M; Hakem R; Miller RG Eur J Immunol; 2003 Mar; 33(3):769-78. PubMed ID: 12616497 [TBL] [Abstract][Full Text] [Related]
8. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production. Majlessi L; Bordenave G J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974 [TBL] [Abstract][Full Text] [Related]
9. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373 [TBL] [Abstract][Full Text] [Related]
10. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L). Winter H; Hu HM; Urba WJ; Fox BA J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388 [TBL] [Abstract][Full Text] [Related]
11. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice. Li Q; Nakadai A; Takeda K; Kawada T Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847 [TBL] [Abstract][Full Text] [Related]
12. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [TBL] [Abstract][Full Text] [Related]
13. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection. Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431 [TBL] [Abstract][Full Text] [Related]
14. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements. Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121 [TBL] [Abstract][Full Text] [Related]
15. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Telford WG; Nam SY; Podack ER; Miller RA Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345 [TBL] [Abstract][Full Text] [Related]
17. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. Dao T; Mehal WZ; Crispe IN J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214 [TBL] [Abstract][Full Text] [Related]
18. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939 [TBL] [Abstract][Full Text] [Related]
19. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579 [TBL] [Abstract][Full Text] [Related]